UBS Adjusts ResMed Price Target to $210 From $195, Maintains Neutral Rating
UBS Adjusts ResMed Price Target to $210 From $195, Maintains Neutral Rating
瑞思邁股票目標價從195美元上調至210美元，中立評級維持不變。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊